Adeno-Associated Viral Vectors Global Market Report 2025

Global Adeno-Associated Viral Vectors Market Report 2024

Adeno-Associated Viral Vectors Global Market Report 2025 – By Type Of Therapy (Gene Augmentation, Immunotherapy, Other Type Of Therapies), By Type Of Gene Delivery Method Used (Ex Vivo, In Vivo), By Target Therapeutic Area (Genetic Disorders, Hematological Disorders, Infectious Diseases, Metabolic Disorders, Ophthalmic Disorders, Muscle Disorders, Neurological Disorders, Other Target Therapeutic Areas ), By Scale Of Operation (Preclinical, Clinical, Commercial), By Application Area (Gene Therapy, Cell Therapy, Vaccines) – Market Size, Trends, And Global Forecast 2025-2034

Name: Adeno-Associated Viral Vectors Global Market Report 2025
Creator: The Business Research Company
License: https://www.thebusinessresearchcompany.com/privacy-policy

Adeno-Associated Viral Vectors Global Market Report 2025

Report Price : $4490.00 | Pages : 175 | Published : January 2025 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options

Request a Sample

Request For Discount

Customise Your Report

Item added to cart!

Request For Proposal

Request For Regional Data

FAQs

Need assistance or more information before the purchase?

Enquire Before Buying

Adeno-Associated Viral Vectors Global Market Report 2025

Proud Members Of

Adeno-Associated Viral Vectors Market Definition

Adeno-associated viral vectors (AAV) are small, non-pathogenic viruses commonly used in gene therapy. They are engineered to deliver therapeutic genes into target cells, offering potential treatments for genetic disorders, cancers, and other diseases. AAV's safety profile and ability to efficiently infect both dividing and non-dividing cells make them valuable tools in biomedical research and clinical applications.

The main type of adeno-associated viral vectors therapy are gene augmentation, immunotherapy, and others. Gene augmentation is a technique where a functional gene is introduced to replace or supplement a defective or missing gene in a patient's cells. The type of gene delivery method are ex vivo and in vivo, which works on target therapeutic areas such as genetic disorders, hematological disorders, infectious diseases, metabolic disorders, ophthalmic disorders, muscle disorders, neurological disorders, and others. The scale of operation includes preclinical, clinical, and commercial, applied for gene therapy, cell therapy, and vaccines.

Adeno-Associated Viral Vectors Market Segmentation

The adeno-associated viral vectors market covered in this report is segmented –

1) By Type Of Therapy: Gene Augmentation, Immunotherapy, Other Type Of Therapies

2) By Type Of Gene Delivery Method Used: Ex Vivo, In Vivo

3) By Target Therapeutic Area: Genetic Disorders, Hematological Disorders, Infectious Diseases, Metabolic Disorders, Ophthalmic Disorders, Muscle Disorders, Neurological Disorders, Other Target Therapeutic Areas

4) By Scale Of Operation: Preclinical, Clinical, Commercial

5) By Application Area: Gene Therapy, Cell Therapy, Vaccines

Subsegments:

1) By Gene Augmentation: Inherited Genetic Disorders, Muscular Dystrophy, Cystic Fibrosis, Hemophilia

2) By Immunotherapy: Cancer Immunotherapy, Viral Infections Immunotherapy, Autoimmune Diseases Immunotherapy

3) By Other Types Of Therapies: Gene Editing, RNA Therapy, Antiviral Therapy

Adeno-Associated Viral Vectors Market Size and growth rate 2025 to 2029: Graph

Adeno-Associated Viral Vectors Market Size 2025 And Growth Rate

The adeno-associated viral vectors market size has grown rapidly in recent years. It will grow from $2.69 billion in 2024 to $3.17 billion in 2025 at a compound annual growth rate (CAGR) of 17.9%. The growth in the historic period can be attributed to vaccine development, increased funding and investment, academic and industrial collaborations, expansion of clinical trials, and public awareness and advocacy.

Adeno-Associated Viral Vectors Market Growth Forecast

The adeno-associated viral vectors market size is expected to see rapid growth in the next few years. It will grow to $6.08 billion in 2029 at a compound annual growth rate (CAGR) of 17.6%. The growth in the forecast period can be attributed to expanding therapeutic applications, increasing the prevalence of genetic disorders, and neurological disorders, regulatory approvals and support, and cost reductions in production. Major trends in the forecast period include gene therapy advancements, technological innovations, scalable manufacturing processes, collaborations and investments, and technological advancements.

Book your 30 minutes free consultation with our research experts

Adeno-Associated Viral Vectors Market Driver: Rising Prevalence Of Genetic Disorders Fuels Growth In The Adeno-Associated Viral Vectors Market

The increasing prevalence of genetic disorders is expected to propel the growth of the adeno-associated viral vectors market going forward. Genetic disorders are conditions caused by abnormalities in an individual's DNA, leading to physical or developmental abnormalities. The improved diagnostic techniques, greater awareness, and higher reproductive age, along with environmental factors and genetic drift are leading to the rise in the prevalence of genetic disorders. Adeno-associated viral vectors are utilized in gene therapy for genetic disorders, delivering corrective genes into target cells to potentially treat conditions like muscular dystrophy or cystic fibrosis. For instance, in February 2023, according to the World Health Organization (WHO), a Switzerland-based specialized agency of the United Nations responsible for international public health, congenital diseases caused an estimated 240,000 baby deaths globally within 28 days of birth each year. An additional 170,000 children between the ages of 1 month and 5 years die as a result of congenital diseases. Therefore, the increasing prevalence of genetic disorders is driving the adeno-associated viral vectors market.

Global Adeno-Associated Viral Vectors Market Major Players

Major companies operating in the adeno-associated viral vectors market are Pfizer Inc., Astellas Pharma, Biogen Inc., Charles River Laboratories International Inc., BioMarin Pharmaceutical Inc., Sarepta Therapeutics Inc., PTC Therapeutics, Ultragenyx Pharmaceutical, Amicus Therapeutics Inc., Oxford Biomedica, Asklepios BioPharmaceutical Inc., uniQure biopharma B.V., Spark Therapeutics Inc., Akouos inc., Adverum Biotechnologies Inc., Passage Bio Inc., AVROBIO Inc, MeiraGTx Holdings plc, GenSight Biologics S.A., Freeline Therapeutics, Aspa Therapeutics Inc., Adrenas Therapeutics Inc., 4D Molecular Therapeutics, Abeona Therapeutics Inc., Neurophth Therapeutics

Global Adeno-Associated Viral Vectors Market Trend: Advancements In Off-the-Shelf Rep/Cap Plasmids

Major companies operating in the adeno-associated viral vectors market are focusing on offering off-the-shelf availability of replication-capsid plasmid to gain a competitive edge in the market. Rep/Cap plasmids, commonly utilized in gene therapy for adeno-associated virus (AAV) vector production, are readily available from numerous commercial suppliers catering to molecular biology research needs. For instance, in January 2024, Charles River Laboratories International Inc., a US-based pharmaceutical company, introduced off-the-shelf replication-capsid plasmid range streamlines AAV-based gene therapy initiatives. This expansion of their product portfolio complements existing lentiviral packaging and AAV Helper plasmid offerings, cutting manufacturing efforts by as much as 66%. These ready-to-use plasmids undergo batch production with meticulous documentation, adhering to CMC guidelines and accompanied by Certification of Analysis (COA) to facilitate IND and Clinical Trial Application (CTA) submissions.

Adeno-Associated Viral Vectors Market Merger And Acquisition: Merck KGaA Strengthens Life Sciences Portfolio With Acquisition Of Mirus Bio LLC

In May 2024, Merck KGaA, a Germany-based company that offers pharmaceuticals, biotechnology, and chemical materials acquired Mirus Bio LLC for $600 million. With this acquisition, Merck KGaA aims to enhance its capabilities in the life sciences sector by integrating Mirus Bio LLC’s advanced technologies for RNA-based research and therapeutic applications, thereby strengthening its position in the growing market for genetic engineering and biotechnology solutions, and furthering its commitment to developing innovative biopharmaceutical products. Mirus Bio LLC is a US-based company that offers adeno-associated viral (AAV) vectors and gene delivery technologies.

Regional Outlook For The Global Adeno-Associated Viral Vectors Market

North America was the largest region in the adeno-associated viral vectors market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the adeno-associated viral vectors market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the adeno-associated viral vectors market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Adeno-Associated Viral Vectors Market?

The adeno-associated viral vectors market consists of sales of recombinant adeno-associated viral vectors (AAV), serotype-specific adeno-associated viral vectors (AAV), and custom adeno-associated viral vectors (AAV). Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Adeno-Associated Viral Vectors Industry?

The adeno-associated viral vectors market research report is one of a series of new reports from The Business Research Company that provides adeno-associated viral vectors market statistics, including adeno-associated viral vectors industry global market size, regional shares, competitors with a adeno-associated viral vectors market share, detailed adeno-associated viral vectors market segments, market trends and opportunities, and any further data you may need to thrive in the adeno-associated viral vectors industry. This adeno-associated viral vectors market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Adeno-Associated Viral Vectors Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2025	$3.17 billion
Revenue Forecast In 2034	$6.08 billion
Growth Rate	CAGR of 17.6% from 2025 to 2034
Base Year For Estimation	2024
Actual Estimates/Historical Data	2019-2024
Forecast Period	2025 - 2029 - 2034
Market Representation	Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered	1) By Type Of Therapy: Gene Augmentation, Immunotherapy, Other Type Of Therapies 2) By Type Of Gene Delivery Method Used: Ex Vivo, In Vivo 3) By Target Therapeutic Area: Genetic Disorders, Hematological Disorders, Infectious Diseases, Metabolic Disorders, Ophthalmic Disorders, Muscle Disorders, Neurological Disorders, Other Target Therapeutic Areas 4) By Scale Of Operation: Preclinical, Clinical, Commercial 5) By Application Area: Gene Therapy, Cell Therapy, Vaccines Subsegments: 1) By Gene Augmentation: Inherited Genetic Disorders, Muscular Dystrophy, Cystic Fibrosis, Hemophilia 2) By Immunotherapy: Cancer Immunotherapy, Viral Infections Immunotherapy, Autoimmune Diseases Immunotherapy 3) By Other Types Of Therapies: Gene Editing, RNA Therapy, Antiviral Therapy
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled	Pfizer Inc., Astellas Pharma, Biogen Inc., Charles River Laboratories International Inc., BioMarin Pharmaceutical Inc., Sarepta Therapeutics Inc., PTC Therapeutics, Ultragenyx Pharmaceutical, Amicus Therapeutics Inc., Oxford Biomedica, Asklepios BioPharmaceutical Inc., uniQure biopharma B.V., Spark Therapeutics Inc., Akouos inc., Adverum Biotechnologies Inc., Passage Bio Inc., AVROBIO Inc, MeiraGTx Holdings plc, GenSight Biologics S.A., Freeline Therapeutics, Aspa Therapeutics Inc., Adrenas Therapeutics Inc., 4D Molecular Therapeutics, Abeona Therapeutics Inc., Neurophth Therapeutics
Customization Scope	Request for Sample
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

2. Adeno-Associated Viral Vectors Market Characteristics

3. Adeno-Associated Viral Vectors Market Trends And Strategies

4. Adeno-Associated Viral Vectors Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Adeno-Associated Viral Vectors Growth Analysis And Strategic Analysis Framework

5.1. Global Adeno-Associated Viral Vectors PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Adeno-Associated Viral Vectors Market Growth Rate Analysis

5.4. Global Adeno-Associated Viral Vectors Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Adeno-Associated Viral Vectors Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Adeno-Associated Viral Vectors Total Addressable Market (TAM)

6. Adeno-Associated Viral Vectors Market Segmentation

6.1. Global Adeno-Associated Viral Vectors Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Gene Augmentation

Immunotherapy

Other Type Of Therapies

6.2. Global Adeno-Associated Viral Vectors Market, Segmentation By Type Of Gene Delivery Method Used, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Ex Vivo

In Vivo

6.3. Global Adeno-Associated Viral Vectors Market, Segmentation By Target Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Genetic Disorders

Hematological Disorders

Infectious Diseases

Metabolic Disorders

Ophthalmic Disorders

Muscle Disorders

Neurological Disorders

Other Target Therapeutic Areas

6.4. Global Adeno-Associated Viral Vectors Market, Segmentation By Scale Of Operation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Preclinical

Clinical

Commercial

6.5. Global Adeno-Associated Viral Vectors Market, Segmentation By Application Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Gene Therapy

Cell Therapy

Vaccines

6.6. Global Adeno-Associated Viral Vectors Market, Sub-Segmentation Of Gene Augmentation, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Inherited Genetic Disorders

Muscular Dystrophy

Cystic Fibrosis

Hemophilia

6.7. Global Adeno-Associated Viral Vectors Market, Sub-Segmentation Of Immunotherapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Cancer Immunotherapy

Viral Infections Immunotherapy

Autoimmune Diseases Immunotherapy

6.8. Global Adeno-Associated Viral Vectors Market, Sub-Segmentation Of Other Types Of Therapies, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Gene Editing

RNA Therapy

Antiviral Therapy

7. Adeno-Associated Viral Vectors Market Regional And Country Analysis

7.1. Global Adeno-Associated Viral Vectors Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Adeno-Associated Viral Vectors Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Adeno-Associated Viral Vectors Market

8.1. Asia-Pacific Adeno-Associated Viral Vectors Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Adeno-Associated Viral Vectors Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Adeno-Associated Viral Vectors Market, Segmentation By Type Of Gene Delivery Method Used, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Adeno-Associated Viral Vectors Market, Segmentation By Target Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Adeno-Associated Viral Vectors Market

9.1. China Adeno-Associated Viral Vectors Market Overview

9.2. China Adeno-Associated Viral Vectors Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Adeno-Associated Viral Vectors Market, Segmentation By Type Of Gene Delivery Method Used, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Adeno-Associated Viral Vectors Market, Segmentation By Target Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Adeno-Associated Viral Vectors Market

10.1. India Adeno-Associated Viral Vectors Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Adeno-Associated Viral Vectors Market, Segmentation By Type Of Gene Delivery Method Used, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Adeno-Associated Viral Vectors Market, Segmentation By Target Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Adeno-Associated Viral Vectors Market

11.1. Japan Adeno-Associated Viral Vectors Market Overview

11.2. Japan Adeno-Associated Viral Vectors Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Adeno-Associated Viral Vectors Market, Segmentation By Type Of Gene Delivery Method Used, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Adeno-Associated Viral Vectors Market, Segmentation By Target Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Adeno-Associated Viral Vectors Market

12.1. Australia Adeno-Associated Viral Vectors Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Adeno-Associated Viral Vectors Market, Segmentation By Type Of Gene Delivery Method Used, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Adeno-Associated Viral Vectors Market, Segmentation By Target Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Adeno-Associated Viral Vectors Market

13.1. Indonesia Adeno-Associated Viral Vectors Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Adeno-Associated Viral Vectors Market, Segmentation By Type Of Gene Delivery Method Used, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Adeno-Associated Viral Vectors Market, Segmentation By Target Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Adeno-Associated Viral Vectors Market

14.1. South Korea Adeno-Associated Viral Vectors Market Overview

14.2. South Korea Adeno-Associated Viral Vectors Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Adeno-Associated Viral Vectors Market, Segmentation By Type Of Gene Delivery Method Used, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Adeno-Associated Viral Vectors Market, Segmentation By Target Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Adeno-Associated Viral Vectors Market

15.1. Western Europe Adeno-Associated Viral Vectors Market Overview

15.2. Western Europe Adeno-Associated Viral Vectors Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Adeno-Associated Viral Vectors Market, Segmentation By Type Of Gene Delivery Method Used, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Adeno-Associated Viral Vectors Market, Segmentation By Target Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Adeno-Associated Viral Vectors Market

16.1. UK Adeno-Associated Viral Vectors Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Adeno-Associated Viral Vectors Market, Segmentation By Type Of Gene Delivery Method Used, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Adeno-Associated Viral Vectors Market, Segmentation By Target Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Adeno-Associated Viral Vectors Market

17.1. Germany Adeno-Associated Viral Vectors Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Adeno-Associated Viral Vectors Market, Segmentation By Type Of Gene Delivery Method Used, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Adeno-Associated Viral Vectors Market, Segmentation By Target Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Adeno-Associated Viral Vectors Market

18.1. France Adeno-Associated Viral Vectors Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Adeno-Associated Viral Vectors Market, Segmentation By Type Of Gene Delivery Method Used, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Adeno-Associated Viral Vectors Market, Segmentation By Target Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Adeno-Associated Viral Vectors Market

19.1. Italy Adeno-Associated Viral Vectors Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Adeno-Associated Viral Vectors Market, Segmentation By Type Of Gene Delivery Method Used, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Adeno-Associated Viral Vectors Market, Segmentation By Target Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Adeno-Associated Viral Vectors Market

20.1. Spain Adeno-Associated Viral Vectors Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Adeno-Associated Viral Vectors Market, Segmentation By Type Of Gene Delivery Method Used, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Adeno-Associated Viral Vectors Market, Segmentation By Target Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Adeno-Associated Viral Vectors Market

21.1. Eastern Europe Adeno-Associated Viral Vectors Market Overview

21.2. Eastern Europe Adeno-Associated Viral Vectors Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Adeno-Associated Viral Vectors Market, Segmentation By Type Of Gene Delivery Method Used, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Adeno-Associated Viral Vectors Market, Segmentation By Target Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Adeno-Associated Viral Vectors Market

22.1. Russia Adeno-Associated Viral Vectors Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Adeno-Associated Viral Vectors Market, Segmentation By Type Of Gene Delivery Method Used, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Adeno-Associated Viral Vectors Market, Segmentation By Target Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Adeno-Associated Viral Vectors Market

23.1. North America Adeno-Associated Viral Vectors Market Overview

23.2. North America Adeno-Associated Viral Vectors Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Adeno-Associated Viral Vectors Market, Segmentation By Type Of Gene Delivery Method Used, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Adeno-Associated Viral Vectors Market, Segmentation By Target Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Adeno-Associated Viral Vectors Market

24.1. USA Adeno-Associated Viral Vectors Market Overview

24.2. USA Adeno-Associated Viral Vectors Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Adeno-Associated Viral Vectors Market, Segmentation By Type Of Gene Delivery Method Used, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Adeno-Associated Viral Vectors Market, Segmentation By Target Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Adeno-Associated Viral Vectors Market

25.1. Canada Adeno-Associated Viral Vectors Market Overview

25.2. Canada Adeno-Associated Viral Vectors Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Adeno-Associated Viral Vectors Market, Segmentation By Type Of Gene Delivery Method Used, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Adeno-Associated Viral Vectors Market, Segmentation By Target Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Adeno-Associated Viral Vectors Market

26.1. South America Adeno-Associated Viral Vectors Market Overview

26.2. South America Adeno-Associated Viral Vectors Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Adeno-Associated Viral Vectors Market, Segmentation By Type Of Gene Delivery Method Used, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Adeno-Associated Viral Vectors Market, Segmentation By Target Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Adeno-Associated Viral Vectors Market

27.1. Brazil Adeno-Associated Viral Vectors Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Adeno-Associated Viral Vectors Market, Segmentation By Type Of Gene Delivery Method Used, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Adeno-Associated Viral Vectors Market, Segmentation By Target Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Adeno-Associated Viral Vectors Market

28.1. Middle East Adeno-Associated Viral Vectors Market Overview

28.2. Middle East Adeno-Associated Viral Vectors Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Adeno-Associated Viral Vectors Market, Segmentation By Type Of Gene Delivery Method Used, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Adeno-Associated Viral Vectors Market, Segmentation By Target Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Adeno-Associated Viral Vectors Market

29.1. Africa Adeno-Associated Viral Vectors Market Overview

29.2. Africa Adeno-Associated Viral Vectors Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Adeno-Associated Viral Vectors Market, Segmentation By Type Of Gene Delivery Method Used, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Adeno-Associated Viral Vectors Market, Segmentation By Target Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Adeno-Associated Viral Vectors Market Competitive Landscape And Company Profiles

30.1. Adeno-Associated Viral Vectors Market Competitive Landscape

30.2. Adeno-Associated Viral Vectors Market Company Profiles

30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Astellas Pharma Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Biogen Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Charles River Laboratories International Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.5. BioMarin Pharmaceutical Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Adeno-Associated Viral Vectors Market Other Major And Innovative Companies

31.1. Sarepta Therapeutics Inc.

31.2. PTC Therapeutics

31.3. Ultragenyx Pharmaceutical

31.4. Amicus Therapeutics Inc.

31.5. Oxford Biomedica

31.6. Asklepios BioPharmaceutical Inc.

31.7. uniQure biopharma B.V.

31.8. Spark Therapeutics Inc.

31.9. Akouos inc.

31.10. Adverum Biotechnologies Inc.

31.11. Passage Bio Inc.

31.12. AVROBIO Inc

31.13. MeiraGTx Holdings plc

31.14. GenSight Biologics S.A.

31.15. Freeline Therapeutics

32. Global Adeno-Associated Viral Vectors Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Adeno-Associated Viral Vectors Market

34. Recent Developments In The Adeno-Associated Viral Vectors Market

35. Adeno-Associated Viral Vectors Market High Potential Countries, Segments and Strategies

35.1 Adeno-Associated Viral Vectors Market In 2029 - Countries Offering Most New Opportunities

35.2 Adeno-Associated Viral Vectors Market In 2029 - Segments Offering Most New Opportunities

35.3 Adeno-Associated Viral Vectors Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Historic Market Growth, 2019-2024, $ Billion

Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Table 3: Global Adeno-Associated Viral Vectors Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 4: Global Adeno-Associated Viral Vectors Market, Segmentation By Type Of Gene Delivery Method Used, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 5: Global Adeno-Associated Viral Vectors Market, Segmentation By Target Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 6: Global Adeno-Associated Viral Vectors Market, Segmentation By Scale Of Operation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 7: Global Adeno-Associated Viral Vectors Market, Segmentation By Application Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 8: Global Adeno-Associated Viral Vectors Market, Sub-Segmentation Of Gene Augmentation, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 9: Global Adeno-Associated Viral Vectors Market, Sub-Segmentation Of Immunotherapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 10: Global Adeno-Associated Viral Vectors Market, Sub-Segmentation Of Other Types Of Therapies, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 11: Global Adeno-Associated Viral Vectors Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 12: Global Adeno-Associated Viral Vectors Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 13: Asia-Pacific, Adeno-Associated Viral Vectors Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 14: Asia-Pacific, Adeno-Associated Viral Vectors Market, Segmentation By Type Of Gene Delivery Method Used, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 15: Asia-Pacific, Adeno-Associated Viral Vectors Market, Segmentation By Target Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 16: China, Adeno-Associated Viral Vectors Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 17: China, Adeno-Associated Viral Vectors Market, Segmentation By Type Of Gene Delivery Method Used, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 18: China, Adeno-Associated Viral Vectors Market, Segmentation By Target Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 19: India, Adeno-Associated Viral Vectors Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 20: India, Adeno-Associated Viral Vectors Market, Segmentation By Type Of Gene Delivery Method Used, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 21: India, Adeno-Associated Viral Vectors Market, Segmentation By Target Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 22: Japan, Adeno-Associated Viral Vectors Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 23: Japan, Adeno-Associated Viral Vectors Market, Segmentation By Type Of Gene Delivery Method Used, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 24: Japan, Adeno-Associated Viral Vectors Market, Segmentation By Target Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 25: Australia, Adeno-Associated Viral Vectors Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 26: Australia, Adeno-Associated Viral Vectors Market, Segmentation By Type Of Gene Delivery Method Used, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 27: Australia, Adeno-Associated Viral Vectors Market, Segmentation By Target Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 28: Indonesia, Adeno-Associated Viral Vectors Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 29: Indonesia, Adeno-Associated Viral Vectors Market, Segmentation By Type Of Gene Delivery Method Used, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 30: Indonesia, Adeno-Associated Viral Vectors Market, Segmentation By Target Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 31: South Korea, Adeno-Associated Viral Vectors Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 32: South Korea, Adeno-Associated Viral Vectors Market, Segmentation By Type Of Gene Delivery Method Used, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 33: South Korea, Adeno-Associated Viral Vectors Market, Segmentation By Target Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 34: Western Europe, Adeno-Associated Viral Vectors Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 35: Western Europe, Adeno-Associated Viral Vectors Market, Segmentation By Type Of Gene Delivery Method Used, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 36: Western Europe, Adeno-Associated Viral Vectors Market, Segmentation By Target Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 37: UK, Adeno-Associated Viral Vectors Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 38: UK, Adeno-Associated Viral Vectors Market, Segmentation By Type Of Gene Delivery Method Used, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 39: UK, Adeno-Associated Viral Vectors Market, Segmentation By Target Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 40: Germany, Adeno-Associated Viral Vectors Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 41: Germany, Adeno-Associated Viral Vectors Market, Segmentation By Type Of Gene Delivery Method Used, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 42: Germany, Adeno-Associated Viral Vectors Market, Segmentation By Target Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 43: France, Adeno-Associated Viral Vectors Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 44: France, Adeno-Associated Viral Vectors Market, Segmentation By Type Of Gene Delivery Method Used, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 45: France, Adeno-Associated Viral Vectors Market, Segmentation By Target Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 46: Italy, Adeno-Associated Viral Vectors Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 47: Italy, Adeno-Associated Viral Vectors Market, Segmentation By Type Of Gene Delivery Method Used, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 48: Italy, Adeno-Associated Viral Vectors Market, Segmentation By Target Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 49: Spain, Adeno-Associated Viral Vectors Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 50: Spain, Adeno-Associated Viral Vectors Market, Segmentation By Type Of Gene Delivery Method Used, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 51: Spain, Adeno-Associated Viral Vectors Market, Segmentation By Target Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 52: Eastern Europe, Adeno-Associated Viral Vectors Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 53: Eastern Europe, Adeno-Associated Viral Vectors Market, Segmentation By Type Of Gene Delivery Method Used, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 54: Eastern Europe, Adeno-Associated Viral Vectors Market, Segmentation By Target Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 55: Russia, Adeno-Associated Viral Vectors Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 56: Russia, Adeno-Associated Viral Vectors Market, Segmentation By Type Of Gene Delivery Method Used, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 57: Russia, Adeno-Associated Viral Vectors Market, Segmentation By Target Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 58: North America, Adeno-Associated Viral Vectors Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 59: North America, Adeno-Associated Viral Vectors Market, Segmentation By Type Of Gene Delivery Method Used, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 60: North America, Adeno-Associated Viral Vectors Market, Segmentation By Target Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 61: USA, Adeno-Associated Viral Vectors Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 62: USA, Adeno-Associated Viral Vectors Market, Segmentation By Type Of Gene Delivery Method Used, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 63: USA, Adeno-Associated Viral Vectors Market, Segmentation By Target Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 64: Canada, Adeno-Associated Viral Vectors Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 65: Canada, Adeno-Associated Viral Vectors Market, Segmentation By Type Of Gene Delivery Method Used, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 66: Canada, Adeno-Associated Viral Vectors Market, Segmentation By Target Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 67: South America, Adeno-Associated Viral Vectors Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 68: South America, Adeno-Associated Viral Vectors Market, Segmentation By Type Of Gene Delivery Method Used, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 69: South America, Adeno-Associated Viral Vectors Market, Segmentation By Target Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 70: Brazil, Adeno-Associated Viral Vectors Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 71: Brazil, Adeno-Associated Viral Vectors Market, Segmentation By Type Of Gene Delivery Method Used, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 72: Brazil, Adeno-Associated Viral Vectors Market, Segmentation By Target Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 73: Middle East, Adeno-Associated Viral Vectors Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 74: Middle East, Adeno-Associated Viral Vectors Market, Segmentation By Type Of Gene Delivery Method Used, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 75: Middle East, Adeno-Associated Viral Vectors Market, Segmentation By Target Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 76: Africa, Adeno-Associated Viral Vectors Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 77: Africa, Adeno-Associated Viral Vectors Market, Segmentation By Type Of Gene Delivery Method Used, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 78: Africa, Adeno-Associated Viral Vectors Market, Segmentation By Target Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 79: Pfizer Inc. Financial Performance

Table 80: Astellas Pharma Financial Performance

Table 81: Biogen Inc. Financial Performance

Table 82: Charles River Laboratories International Inc. Financial Performance

Table 83: BioMarin Pharmaceutical Inc. Financial Performance

List Of Figures

Figure 1: Global Historic Market Growth, 2019-2024, $ Billion

Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Figure 3: Global Adeno-Associated Viral Vectors Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 4: Global Adeno-Associated Viral Vectors Market, Segmentation By Type Of Gene Delivery Method Used, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 5: Global Adeno-Associated Viral Vectors Market, Segmentation By Target Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 6: Global Adeno-Associated Viral Vectors Market, Segmentation By Scale Of Operation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 7: Global Adeno-Associated Viral Vectors Market, Segmentation By Application Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 8: Global Adeno-Associated Viral Vectors Market, Sub-Segmentation Of Gene Augmentation, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 9: Global Adeno-Associated Viral Vectors Market, Sub-Segmentation Of Immunotherapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 10: Global Adeno-Associated Viral Vectors Market, Sub-Segmentation Of Other Types Of Therapies, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 11: Global Adeno-Associated Viral Vectors Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 12: Global Adeno-Associated Viral Vectors Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 13: Asia-Pacific, Adeno-Associated Viral Vectors Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 14: Asia-Pacific, Adeno-Associated Viral Vectors Market, Segmentation By Type Of Gene Delivery Method Used, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 15: Asia-Pacific, Adeno-Associated Viral Vectors Market, Segmentation By Target Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 16: China, Adeno-Associated Viral Vectors Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 17: China, Adeno-Associated Viral Vectors Market, Segmentation By Type Of Gene Delivery Method Used, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 18: China, Adeno-Associated Viral Vectors Market, Segmentation By Target Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 19: India, Adeno-Associated Viral Vectors Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 20: India, Adeno-Associated Viral Vectors Market, Segmentation By Type Of Gene Delivery Method Used, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 21: India, Adeno-Associated Viral Vectors Market, Segmentation By Target Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 22: Japan, Adeno-Associated Viral Vectors Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 23: Japan, Adeno-Associated Viral Vectors Market, Segmentation By Type Of Gene Delivery Method Used, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 24: Japan, Adeno-Associated Viral Vectors Market, Segmentation By Target Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 25: Australia, Adeno-Associated Viral Vectors Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 26: Australia, Adeno-Associated Viral Vectors Market, Segmentation By Type Of Gene Delivery Method Used, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 27: Australia, Adeno-Associated Viral Vectors Market, Segmentation By Target Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 28: Indonesia, Adeno-Associated Viral Vectors Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 29: Indonesia, Adeno-Associated Viral Vectors Market, Segmentation By Type Of Gene Delivery Method Used, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 30: Indonesia, Adeno-Associated Viral Vectors Market, Segmentation By Target Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 31: South Korea, Adeno-Associated Viral Vectors Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 32: South Korea, Adeno-Associated Viral Vectors Market, Segmentation By Type Of Gene Delivery Method Used, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 33: South Korea, Adeno-Associated Viral Vectors Market, Segmentation By Target Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 34: Western Europe, Adeno-Associated Viral Vectors Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 35: Western Europe, Adeno-Associated Viral Vectors Market, Segmentation By Type Of Gene Delivery Method Used, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 36: Western Europe, Adeno-Associated Viral Vectors Market, Segmentation By Target Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 37: UK, Adeno-Associated Viral Vectors Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 38: UK, Adeno-Associated Viral Vectors Market, Segmentation By Type Of Gene Delivery Method Used, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 39: UK, Adeno-Associated Viral Vectors Market, Segmentation By Target Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 40: Germany, Adeno-Associated Viral Vectors Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 41: Germany, Adeno-Associated Viral Vectors Market, Segmentation By Type Of Gene Delivery Method Used, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 42: Germany, Adeno-Associated Viral Vectors Market, Segmentation By Target Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 43: France, Adeno-Associated Viral Vectors Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 44: France, Adeno-Associated Viral Vectors Market, Segmentation By Type Of Gene Delivery Method Used, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 45: France, Adeno-Associated Viral Vectors Market, Segmentation By Target Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 46: Italy, Adeno-Associated Viral Vectors Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 47: Italy, Adeno-Associated Viral Vectors Market, Segmentation By Type Of Gene Delivery Method Used, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 48: Italy, Adeno-Associated Viral Vectors Market, Segmentation By Target Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 49: Spain, Adeno-Associated Viral Vectors Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 50: Spain, Adeno-Associated Viral Vectors Market, Segmentation By Type Of Gene Delivery Method Used, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 51: Spain, Adeno-Associated Viral Vectors Market, Segmentation By Target Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 52: Eastern Europe, Adeno-Associated Viral Vectors Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 53: Eastern Europe, Adeno-Associated Viral Vectors Market, Segmentation By Type Of Gene Delivery Method Used, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 54: Eastern Europe, Adeno-Associated Viral Vectors Market, Segmentation By Target Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 55: Russia, Adeno-Associated Viral Vectors Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 56: Russia, Adeno-Associated Viral Vectors Market, Segmentation By Type Of Gene Delivery Method Used, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 57: Russia, Adeno-Associated Viral Vectors Market, Segmentation By Target Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 58: North America, Adeno-Associated Viral Vectors Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 59: North America, Adeno-Associated Viral Vectors Market, Segmentation By Type Of Gene Delivery Method Used, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 60: North America, Adeno-Associated Viral Vectors Market, Segmentation By Target Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 61: USA, Adeno-Associated Viral Vectors Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 62: USA, Adeno-Associated Viral Vectors Market, Segmentation By Type Of Gene Delivery Method Used, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 63: USA, Adeno-Associated Viral Vectors Market, Segmentation By Target Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 64: Canada, Adeno-Associated Viral Vectors Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 65: Canada, Adeno-Associated Viral Vectors Market, Segmentation By Type Of Gene Delivery Method Used, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 66: Canada, Adeno-Associated Viral Vectors Market, Segmentation By Target Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 67: South America, Adeno-Associated Viral Vectors Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 68: South America, Adeno-Associated Viral Vectors Market, Segmentation By Type Of Gene Delivery Method Used, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 69: South America, Adeno-Associated Viral Vectors Market, Segmentation By Target Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 70: Brazil, Adeno-Associated Viral Vectors Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 71: Brazil, Adeno-Associated Viral Vectors Market, Segmentation By Type Of Gene Delivery Method Used, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 72: Brazil, Adeno-Associated Viral Vectors Market, Segmentation By Target Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 73: Middle East, Adeno-Associated Viral Vectors Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 74: Middle East, Adeno-Associated Viral Vectors Market, Segmentation By Type Of Gene Delivery Method Used, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 75: Middle East, Adeno-Associated Viral Vectors Market, Segmentation By Target Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 76: Africa, Adeno-Associated Viral Vectors Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 77: Africa, Adeno-Associated Viral Vectors Market, Segmentation By Type Of Gene Delivery Method Used, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 78: Africa, Adeno-Associated Viral Vectors Market, Segmentation By Target Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 79: Pfizer Inc. Financial Performance

Figure 80: Astellas Pharma Financial Performance

Figure 81: Biogen Inc. Financial Performance

Figure 82: Charles River Laboratories International Inc. Financial Performance

Figure 83: BioMarin Pharmaceutical Inc. Financial Performance

Forecasting Till 2030: Opportunities And Strategies In The Global Value Based Care Payment Market – Includes Value Based Care Payment Market Analysis

How Will The Nuclear Medicine Market Grow In 2022?

What Is The Pediatric Imaging Market Overview In 2022?

Latest Healthcare Technology Management Market Growth Study 2022-2026 By The Business Research Company

The Business Research Company offers the medical aesthetics market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the clinical chemistry market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the hospital acquired infection control market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the multiplex assays market research report 2022 with industry size, share, segments and market growth

Viral Vectors And Plasmid DNA Global Market Report 2025 – By Product (Plasmid DNA, Viral Vectors), By Disease (Infectious Diseases, Genetic Disorders, Cancer, Other Diseases), By Application (Gene And Cancer Therapies, Viral Infections, Immunotherapy, Formulation Development, Other Applications), By End User (Research Institutes, Biopharmaceutical And Pharmaceutical Companies) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Bacterial And Plasmid Vectors Global Market Report 2025 – By Host Type (E.Coli Expression Vectors, Other Bacterial Expression Vectors), By Application (Genetics, Molecular Biology, Bioinformatics, Other Applications), By End Users (Hospitals, Homecare, Specialty Clinics, Other End Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Adenosine Triphosphate (ATP) Assays Global Market Report 2025 – By Type (Luminometric ATP (Adenosine Triphosphate) Assays, Enzymatic ATP (Adenosine Triphosphate) Assays, Bioluminescence Resonance Energy Transfer (BRET) ATP (Adenosine Triphosphate) Assays, Cell-Based ATP (Adenosine Triphosphate) Assays, Other Types), By Component (Consumables And Accessories, Instruments), By Application (Drug Discovery And Development, Clinical Diagnostics, Environmental Testing, Food Safety And Quality Testing, Other Applications), By End User (Pharmaceutical And Biotechnology Companies, Food and Beverage Industry, Hospitals And Diagnostics Laboratories, Academic And Research Institutions) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Viral Inactivation Global Market Report 2025 – By Product (Kits And Reagents, Systems, Services), By Method (Solvent Detergent Method, pH Adjustment Method, Pasteurization, Other Methods), By Application (Vaccines And Therapeutics, Tissues And Tissue Products, Blood And Blood Products, Other Applications), By End User (Pharmaceutical And Biotechnology Companies, Contract Research Organizations, Blood Banks, Hospital, Academic Research Institutes, Other End Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

The Antiviral & Antimicrobial Coatings Global Market Report 2025 – By Type (Antimicrobial Coatings, Antiviral Coatings), By Material (Silver, Organic Materials, Copper, Aluminum, Silicon Dioxide), By Form (Liquid, Powder, Aerosol), By Application (Healthcare, Building And Construction, Food And Beverage, Packaging, Automotive, Protective Clothing, Air And Water Treatment) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Antiviral Combination Therapy Global Market Report 2025 – By Type (Branded, Generic), By Drug Combination (Nucleotide Reverse Transcriptase Inhibitors/Non-Nucleotide Reverse Transcriptase Inhibitors, Integrase Inhibitor/Nucleotide Reverse Transcriptase Inhibitors, Nucleotide Reverse Transcriptase Inhibitors, Nucleotide Reverse Transcriptase Inhibitors/Protease Inhibitor, Other Drug Combinations), By Route Of Administration (Oral, Intravenous), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Other Distribution Channels), By Indication (Human Immunodeficiency Virus, Hepatitis, Other Indications) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Viral Gastroenteritis Global Market Report 2025 – By Drugs (Antibiotics, Antacids, Laxatives, Antimotility Agents, Others Drugs), By Diagnosis (Physical Examination, Rapid Stool Test), By Indication (Watery Diarrhea, Abdominal Cramps, Pain, Other Indications), By Type Of Virus (Norovirus, Rotavirus, Astrovirus, Enteric Adenovirus), By End User (Hospitals, Clinics, Pharmaceutical Companies, Diagnostic Centers, Ambulatory Care Centers, Others End Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Viral Vector Manufacturing Global Market Report 2025 – By Type (Adenoviral Vectors, Adeno-Associated Viral Vectors, Lentiviral Vectors, Retroviral Vectors, Other Types), By Disease (Cancer, Genetic Disorders, Infectious Diseases, Other Diseases), By Workflow (Upstream Processing, Downstream Processing), By Application (Gene And Cell Therapy Development, Vaccine Development, Biopharmaceutical And Pharmaceutical Discovery, Biomedical Research), By End-User (Research Organizations, Biotech And Pharmaceutical Companies, Others End Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Frequently Asked Questions

What is the definition of the Adeno-Associated Viral Vectors market?

How will the Adeno-Associated Viral Vectors market drivers and restraints affect the market dynamics? What forces will shape the Adeno-Associated Viral Vectors industry going forward?

The Adeno-Associated Viral Vectors market major growth driver - Rising Prevalence Of Genetic Disorders Fuels Growth In The Adeno-Associated Viral Vectors Market. For further insights on the Adeno-Associated Viral Vectors market, request a sample here

What is the forecast market size or the forecast market value of the Adeno-Associated Viral Vectors market?

The Adeno-Associated Viral Vectors market size has grown strongly in recent years. The adeno-associated viral vectors market size has grown rapidly in recent years. It will grow from $2.69 billion in 2024 to $3.17 billion in 2025 at a compound annual growth rate (CAGR) of 17.9%. The growth in the historic period can be attributed to vaccine development, increased funding and investment, academic and industrial collaborations, expansion of clinical trials, and public awareness and advocacy. The adeno-associated viral vectors market size is expected to see rapid growth in the next few years. It will grow to $6.08 billion in 2029 at a compound annual growth rate (CAGR) of 17.6%. The growth in the forecast period can be attributed to expanding therapeutic applications, increasing the prevalence of genetic disorders, and neurological disorders, regulatory approvals and support, and cost reductions in production. Major trends in the forecast period include gene therapy advancements, technological innovations, scalable manufacturing processes, collaborations and investments, and technological advancements. For further insights on the Adeno-Associated Viral Vectors market, request a sample here

How is the Adeno-Associated Viral Vectors market segmented?

The adeno-associated viral vectors market covered in this report is segmented –
1) By Type Of Therapy: Gene Augmentation, Immunotherapy, Other Type Of Therapies
2) By Type Of Gene Delivery Method Used: Ex Vivo, In Vivo
3) By Target Therapeutic Area: Genetic Disorders, Hematological Disorders, Infectious Diseases, Metabolic Disorders, Ophthalmic Disorders, Muscle Disorders, Neurological Disorders, Other Target Therapeutic Areas
4) By Scale Of Operation: Preclinical, Clinical, Commercial
5) By Application Area: Gene Therapy, Cell Therapy, Vaccines
Subsegments:
1) By Gene Augmentation: Inherited Genetic Disorders, Muscular Dystrophy, Cystic Fibrosis, Hemophilia
2) By Immunotherapy: Cancer Immunotherapy, Viral Infections Immunotherapy, Autoimmune Diseases Immunotherapy
3) By Other Types Of Therapies: Gene Editing, RNA Therapy, Antiviral Therapy For further insights on the Adeno-Associated Viral Vectors market, request a sample here

Which region has the largest share of the Adeno-Associated Viral Vectors market? What are the other regions covered in the report?

North America was the largest region in the adeno-associated viral vectors market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the adeno-associated viral vectors market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on the Adeno-Associated Viral Vectors market, request a sample here.

Who are the major players in the Adeno-Associated Viral Vectors market?

What are the key trends in the Adeno-Associated Viral Vectors market?

Major trends in the Adeno-Associated Viral Vectors market include Advancements In Off-the-Shelf Rep/Cap Plasmids. For further insights on the Adeno-Associated Viral Vectors market, request a sample here.

What are the major opportunities in the Adeno-Associated Viral Vectors market? What are the strategies for the Adeno-Associated Viral Vectors market?

For detailed insights on the major opportunities and strategies in the Adeno-Associated Viral Vectors market, request a sample here.

How does the Adeno-Associated Viral Vectors market relate to the overall economy and other similar markets?

For detailed insights on Adeno-Associated Viral Vectors's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the Adeno-Associated Viral Vectors industry?

For detailed insights on the mergers and acquisitions in the Adeno-Associated Viral Vectors industry, request a sample here.

What are the key dynamics influencing the Adeno-Associated Viral Vectors market growth? SWOT analysis of the Adeno-Associated Viral Vectors market.

For detailed insights on the key dynamics influencing the Adeno-Associated Viral Vectors market growth and SWOT analysis of the Adeno-Associated Viral Vectors industry, request a sample here.